Cano Health Inc (NYSE:CANO) saw an upside of 20.14% to close Monday at $0.27 after adding $0.04 on the day. The 5-day average trading volume is 9,613,681 shares of the company’s common stock. It has gained $0.3265 in the past week and touched a new high 1 time within the past 5 days. An average of 9,858,420 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 13,285,398.
CANO’s 1-month performance is 18.26% or -$0.0530 on its low of $0.2202 reached on 09/21/23. The company’s shares have touched a 52-week low of $0.22 and high of $9.75, with the stock’s rally to the 52-week high happening on 02/08/23. YTD, CANO has lost -80.15% or -$1.0980 and has reached a new high 7 times. However, the current price is down -97.21% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
CANO stock investors last saw insider trading activity on Aug 11.Camerlinck Robert (Chief Operating Officer) most recently sold 30,646 shares at $0.77 per share on Aug 11. This transaction cost the insider $23,453. Chief Clinical Officer, Aguilar Richard, sold 400,000 shares at a price of $1.31 on Jun 29. Then, on Jun 28, Chief Clinical Officer Aguilar Richard sold 150,000 shares at a price of $1.22 per share. This transaction amounted to $183,300.
Valuation Metrics
CANO stock has a beta of 0.34. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.03 while the price-to-book (PB) in the most recent quarter is 0.52.
Cano Health Inc’s quick ratio for the period ended June 29 was 0.49, with the current ratio over the same period at 0.49. As well, the company’s long term debt to equity for the quarter ending June 29 was 7.46, while the total debt to equity was 8.39. In terms of profitability, the gross margin trailing 12 months is 4.86%. The trailing 12-month EBITDA margin is 0.60% while for the period ending June 29, Cano Health Inc’s operating margin was -11.17%. The firm’s gross profit as reported stood at $3.18 billion against revenue of $2.74 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 96.21% to -$140.75 million, while revenue of -$28.15 million was 80.0% off the previous quarter. Analysts expected CANO to announce -$0.12 per share in earnings in its latest quarter, but it posted -$0.51, representing a -325.00% surprise. EBITDA for the quarter stood at more than -$216.94 million. CANO stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 1.47 billion, with total debt at $1.23 billion. Shareholders hold equity totaling $538.68 million.
Let’s look briefly at Cano Health Inc (CANO) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 25 September was 36.88% to suggest the stock is trending Neutral, with historical volatility in this time period at 148.26%.
The stock’s 5-day moving average is $0.2459, reflecting a -12.90% or -$0.0403 change from its current price. CANO is currently trading -16.31% above its 20-day SMA, -74.10% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -80.43% and SMA200 by-84.55%.
Stochastic %K and %D was 10.67% and 6.39% and the average true range (ATR) pointed at 0.0526. The RSI (14) points at 33.53%, while the 14-day stochastic is at 28.12% with the period’s ATR at 0.0661. The stock’s 9-day MACD Oscillator is pointing at -0.0482 and -0.0720 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Cano Health Inc (NYSE: CANO), Jefferies downgraded it to a Hold rating. They previously had a Buy rating on the stock. Analysts offering their rating for CANO stock have a consensus rating for the stock as Hold. Currently, 1 brokerage advisors rate CANO as a “sell,”, while 5 advise that investors “Hold.” 1 analysts have rated the stock as underweight. 0 rates the stock as overweight while 1 have offered a “buy” rating.
What is CANO’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $0.25 and a high of $2.00, with their median price target at $0.65. Looking at these predictions, the average price target given by analysts is for Cano Health Inc (CANO) stock is $0.93.
